Health care industry

FILE - In this Jan. 4, 2019, file photo Rep. Elijah Cummings, D-Md., speaks at the Capitol in Washington, Friday, Jan. 4, 2019. Leading congressional liberals are unveiling a package of bills that aims to reduce what Americans pay for prescription drugs by linking prices to lower costs in other countries. Vermont Independent Sen. Bernie Sanders and Cummings plan to introduce three bills Thursday, Jan. 10. (AP Photo/J. Scott Applewhite, File)
Patrick Gentry
January 14, 2019 - 12:41 pm
WASHINGTON (AP) — House Democrats announced a sweeping investigation Monday of the pharmaceutical industry's pricing practices, jockeying for the upper hand with the Trump administration on an issue that concerns Americans across the political spectrum. Oversight and Reform Committee Chairman...
Read More
FILE - In this Jan. 4, 2019, file photo Rep. Elijah Cummings, D-Md., speaks at the Capitol in Washington, Friday, Jan. 4, 2019. Leading congressional liberals are unveiling a package of bills that aims to reduce what Americans pay for prescription drugs by linking prices to lower costs in other countries. Vermont Independent Sen. Bernie Sanders and Cummings plan to introduce three bills Thursday, Jan. 10. (AP Photo/J. Scott Applewhite, File)
January 10, 2019 - 10:19 am
WASHINGTON (AP) — Challenging the Trump administration on a top consumer issue, leading congressional liberals are proposing legislation that would radically reduce U.S. prescription drug bills by linking prices to lower costs in other countries. The legislation set to be introduced Thursday has...
Read More
People enter New York City Health Hospitals Gouverneur Health building, Tuesday, Jan. 8, 2019, in New York. Mayor Bill de Blasio says New York City will spend up to $100 million per year to expand health care coverage to people without health insurance including immigrants in the U.S. illegally. (AP Photo/Mary Altaffer)
January 08, 2019 - 4:43 pm
NEW YORK (AP) — New York City will spend up to $100 million per year to expand health care coverage to people without health insurance, including immigrants who are in the U.S. illegally, Mayor Bill de Blasio announced Tuesday. The plan involves expanding the city's existing public insurance...
Read More
FILE - In this July 10, 2018 file photo, bottles of prescription medicines ride on a conveyor belt at a pharmacy warehouse in Florence, N.J. According to a report released on Tuesday, Jan. 8, 2018, annual spending by the U.S. health industry on ads and promotions has reached $30 billion. That includes advertisements for prescription drugs that were shown 5 million times on TV and elsewhere in 2016. That’s a huge increase in 20 years and just part of broad health industry efforts to promote drugs, devices, lab tests and even new hospitals. (AP Photo/Julio Cortez, File)
January 08, 2019 - 2:29 pm
Ads for prescription drugs appeared 5 million times in just one year, capping a recent surge in U.S. medical marketing, a new analysis found. The advertisements for various medicines showed up on TV, newspapers, online sites and elsewhere in 2016. Their numbers soared over 20 years as part of broad...
Read More
January 07, 2019 - 3:11 pm
WASHINGTON (AP) — The Supreme Court seemed inclined Monday to side with drugmaker Merck & Co. in a dispute over the warning label on its bone-strengthening drug Fosamax. The justices heard arguments in a case involving hundreds of people who sued the Kenilworth, New Jersey-based drug company,...
Read More
FILE - This April 26, 2017, file photo shows the Eli Lilly & Co. corporate headquarters in Indianapolis. Eli Lilly is buying Loxo Oncology for about $8 billion as it continues to broaden its cancer treatment efforts. Loxo Oncology Inc. is a biopharmaceutical company focused on the development and commercialization of highly selective medicines for patients with genomically defined cancers. (AP Photo/Darron Cummings, File)
January 07, 2019 - 7:49 am
Eli Lilly is spending about $8 billion in cash to buy Loxo Oncology, as the drugmaker bulks up on cancer treatments that target certain gene abnormalities. Loxo Oncology could launch a drug next year and targets an abnormality that occurs in several tumor types, including some lung and thyroid...
Read More
CAPTION CORRECTS DATE TO FEB. 4, 2009 In this Feb. 4, 2009 photo, a view of the exterior of the University Hospital in Enkoping, Sweden, Friday, Jan. 4, 2019. Officials say a Swedish hospital has reported a suspected case of the deadly Ebola virus, adding the patient has been isolated. Region Uppsala, which oversees several hospitals and medical clinics north of Stockholm, says a test had been carried out on the patient who was not identified, adding a result would be available late Friday, Jan. 4, 2019. (Henrik Montgomery/TT News Agency via AP)
January 05, 2019 - 5:21 am
HELSINKI (AP) — Swedish health officials say a suspected Ebola case reported by a hospital has turned out to be a false alarm with tests carried out on the unidentified patient showing no signs of the deadly virus. Medical authorities said late Friday that the young male patient was admitted to an...
Read More
FILE - In this June 15, 2005, file photo, a sign stands in front of a Bristol-Myers Squibb building in a Lawrence Township, N.J. Bristol-Myers Squibb is buying Celgene in a cash-and-stock deal valued at about $74 billion. (AP Photo/Mel Evans, File)
January 03, 2019 - 6:00 pm
SUMMIT, N.J. (AP) — Bristol-Myers Squibb is spending $74 billion on fellow drugmaker Celgene in a deal aimed at stocking the combined company's development pipeline with cancer, immunology and cardiovascular treatments. Bristol would gain the cancer treatment Revlimid in the cash-and-stock deal...
Read More
Stock trader Michael Milano works at the New York Stock Exchange, Wednesday, Dec. 19, 2018. (AP Photo/Mark Lennihan)
December 19, 2018 - 3:42 pm
NEW YORK (AP) — Stocks gave up an early rally and took a dive in afternoon trading after the Federal Reserve's raised interest rates again and said it plans to keep raising them next year. The U.S. central bank also said it wouldn't make any changes in allowing its large bond portfolio to shrink...
Read More
FILE - This April 20, 2009 file photo, shows the British pharmaceuticals firm GlaxoSmithKline in London. Drugmakers GlaxoSmithKline and Pfizer are merging their healthcare divisions, creating a business with combined sales of 9.8 billion pounds ($12.7 billion). British-based Glaxo will own 68 percent of the joint venture, while U.S.-based Pfizer will own the remaining 32 percent stake. (AP Photo/Sang Tan, File)
December 19, 2018 - 1:18 pm
Drugmakers GlaxoSmithKline and Pfizer plan to merge their consumer health businesses into what will be the world leader in sales of nonprescription medicines such as pain relievers, vitamins and cold remedies. The new joint venture would have with combined annual sales of $12.7 billion (9.8 billion...
Read More

Pages